Cargando…
Association of Preexisting Drug-Resistance Mutations and Treatment Failure in Hepatitis B Patients
The role of preexisting minority drug-resistance mutations in treatment failure has not been fully understood in chronic hepatitis B patients. To understand mechanisms of drug resistance, we analyzed drug-resistance mutations in 46 treatment-failure patients and in 29 treatment-naïve patients and de...
Autores principales: | Ma, Jie, Zhang, Yingchun, Chen, Xinyue, Jin, Yi, Chen, Dexi, Wu, Yun, Cui, Jing, Wang, Haitao, Liu, Jia, Li, Ning, Gao, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728369/ https://www.ncbi.nlm.nih.gov/pubmed/23935839 http://dx.doi.org/10.1371/journal.pone.0067606 |
Ejemplares similares
-
Nonattenuated Polymyxin B Used for the Treatment of Extreme-Drug Resistant Acinetobacter baumannii-Related Infections in Patients with Preexisting End Stage Renal Failure
por: Zhou, Yvonne Peijun, et al.
Publicado: (2014) -
High Prevalence of Preexisting HBV Polymerase Mutations in Pregnant Women Does Not Limit the Antiviral Therapy Efficacy
por: Wang, Jing, et al.
Publicado: (2021) -
Preexisting TP53 mutation in therapy-related acute myeloid leukemia
por: Schulz, Eduard, et al.
Publicado: (2014) -
Effect of SARS-COV-2 Diagnosis on Individuals with Preexisting Chronic Heart Failure
por: Annie, Frank H., et al.
Publicado: (2022) -
Norepinephrine, Dopamine, and Vasopressin in Patients with Sepsis and Preexisting or Acute Heart Failure: A Retrospective Cohort Study
por: Zhou, Dandan, et al.
Publicado: (2021)